Aristides Capital’s LifeMD LFMD Stock Holding History

Aristides Capital’s Portfolio LFMD Stock Details LFMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-59,500	Closed	-$203K	–	233
2025 Q4	$203K	Buy	+59,500	New	+$289K	0.04%	176

Other funds holding LFMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1.16B AUM 53.61% 1-Year Est. Return

BRF

B. Riley Financial Los Angeles, California $434M AUM 751.56% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Aristides Capital's LFMD Position: Q1 2026 in Review

Aristides Capital sold out of LifeMD (LFMD) in Q1 2026, closing a stake of 59,500 shares — an estimated $203K sold.

Aristides Capital first reported a position in LFMD in Q4 2025 and held it in 1 quarter. The position peaked at $203K in Q4 2025. 102 funds tracked by Wall St. Rank hold LFMD as of Q1 2026.

Aristides Capital reported no remaining LifeMD position as of Q1 2026 after selling out during the quarter.
Aristides Capital sold 59,500 LifeMD shares in Q1 2026, an estimated $203K.
Aristides Capital first reported a position in LifeMD in Q4 2025 and held it in 1 quarter.
Aristides Capital's LifeMD position peaked at $203K in Q4 2025.
102 funds tracked by Wall St. Rank held LifeMD as of Q1 2026.

Based on Aristides Capital's 13F filing for Q1 2026, filed 14 May 2026.